Narrative review discusses tezepelumab for severe asthma in type 2-low patients on GINA Step 4–5 therapy.
New Asthma Drug Works for Hard-to-Treat Patients Who Had Few Options
This narrative review examines tezepelumab for severe asthma, specifically focusing on type 2-low patients currently prescribed GINA Step 4–…
This new treatment offers hope for severe asthma patients who don’t respond to standard therapies, including a group previously left out of …
Baseline inflammation patterns in severe asthma patients receiving biologic therapy
Severe asthma patients with neutrophilic patterns had lower lung function and more sleep apnea
This retrospective observational cohort study analyzed 103 patients with severe asthma treated with biologic agents. Results described basel…
Severe asthma patients with neutrophilic patterns had lower lung function and more sleep apnea than those with other inflammation types.
Asia-Pacific experts propose clinical remission definition and lung function goals for severe asthma
What does it mean to beat severe asthma in Asia? Experts propose new goals.
A position statement by Asia-Pacific experts reviewed severe asthma management challenges in the region. They proposed a clinical remission …
Experts redefine severe asthma success in Asia by prioritizing symptom control and stability over impossible lung function recovery.
VALIANT: Phase 2 trial of verekitug (UPB-101) for severe asthma completes enrollment of 479 patients
Can a new injection help people with severe asthma breathe easier and avoid dangerous flare-ups?
The VALIANT study, a phase 2 trial, evaluated the efficacy and safety of subcutaneous verekitug (UPB-101) versus placebo in adults with seve…
A new asthma injection aims to reduce dangerous flare-ups and improve breathing for adults with severe asthma in a completed trial.